We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHK icon
826
Mohawk Industries
MHK
$9.42B
$1.58M 0.02%
15,557
+234
+2% +$20.6K
EBS icon
827
Emergent Biosolutions
EBS
$230M
$1.58M 0.02%
20,011
– –
CF icon
828
CF Industries
CF
$17.7B
$1.57M 0.02%
55,915
-130
-0.2% -$3.7K
FRT icon
829
Federal Realty Investment Trust
FRT
$10.3B
$1.57M 0.02%
18,395
+291
+2% +$23.5K
SLM icon
830
SLM Corp
SLM
$5.22B
$1.57M 0.02%
222,751
-19,579
-8% -$146K
ROL icon
831
Rollins
ROL
$17.4B
$1.56M 0.02%
55,290
+850
+2% +$22.8K
BHF icon
832
Brighthouse Financial
BHF
$3.42B
$1.55M 0.02%
55,729
-6,989
-11% -$193K
ADC icon
833
Agree Realty
ADC
$9.34B
$1.55M 0.02%
23,548
+5,642
+32% +$360K
WPX
834
DELISTED
WPX Energy, Inc.
WPX
$1.55M 0.02%
242,508
+3,294
+1% +$18.6K
NVTA
835
DELISTED
Invitae Corporation
NVTA
$1.54M 0.02%
50,959
+11,653
+30% +$203K
GO icon
836
Grocery Outlet
GO
$1.07B
$1.54M 0.02%
+37,776
New +$1.35M
ARNA
837
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.54M 0.02%
24,414
+3,513
+17% +$193K
NTRA icon
838
Natera
NTRA
$44.8B
$1.54M 0.02%
30,787
+3,740
+14% +$150K
WBS icon
839
Webster Financial
WBS
$12.8B
$1.53M 0.02%
53,547
+720
+1% +$19.1K
POWI icon
840
Power Integrations
POWI
$3.48B
$1.53M 0.02%
25,898
+2,752
+12% +$145K
EPR icon
841
EPR Properties
EPR
$4.73B
$1.52M 0.02%
46,011
+975
+2% +$28.9K
BHVN
842
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.52M 0.02%
20,816
+2,407
+13% +$128K
BEN icon
843
Franklin Resources
BEN
$17.2B
$1.52M 0.02%
72,542
+647
+0.9% +$12.2K
RACE icon
844
Ferrari
RACE
$72.5B
$1.52M 0.02%
8,924
– –
CNNE icon
845
Cannae Holdings
CNNE
$675M
$1.51M 0.02%
36,796
+6,470
+21% +$221K
MD icon
846
Pediatrix Medical
MD
$2.14B
$1.5M 0.02%
87,911
+39,523
+82% +$586K
CC icon
847
Chemours
CC
$2.3B
$1.5M 0.02%
97,521
+3,670
+4% +$46.4K
ADNT icon
848
Adient
ADNT
$1.54B
$1.5M 0.02%
91,145
+1,881
+2% +$28.6K
RBC icon
849
RBC Bearings
RBC
$17.5B
$1.49M 0.02%
11,153
+987
+10% +$126K
WLKP icon
850
Westlake Chemical Partners
WLKP
$764M
$1.49M 0.02%
78,907
– –
32 33
34
35 36

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.